Skip to main content
VaccineWatch
VaccinesSymptomsStatesAnalysisToolsDashboardCompare

VaccineWatch

Transparent access to VAERS data for informed decision-making. We present the data as-is, with appropriate context and disclaimers.

Explore Data

  • Vaccines
  • Symptoms
  • Manufacturers
  • States
  • Dashboard
  • Compare Tool
  • Search

Deep Dives

  • The Denominator Problem
  • Onset Timing
  • Lot Number Analysis
  • COVID Impact
  • Myocarditis
  • Death Reports
  • Interactive Tools
  • All 23 Articles →

Resources

  • About
  • Methodology
  • FAQ
  • Glossary
  • Side Effects Guide
  • Vaccine Schedule
  • Vaccine Safety
  • Safety Timeline
  • Adverse Events
  • Is VAERS Reliable?
  • Report an Event
  • Disclaimer
  • VAERS Official Site ↗

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending
  • OpenMedicare
  • OpenLobby
  • TheDataProject.ai

Data source: VAERS (Vaccine Adverse Event Reporting System)

Data through 2026 · Updated quarterly

Built by TheDataProject.ai · © 2026 VaccineWatch

Important: VAERS accepts reports of adverse events following vaccination. For any given report, there is no certainty that the reported event was caused by the vaccine. Reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. Most reports to VAERS are voluntary, which means they are subject to biases. This data cannot be used to determine if vaccines cause or contribute to adverse events.

⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

  1. Home
  2. Vaccines
  3. Rubella (Meruvax II)

Rubella (Meruvax II)

RUB1,021 total reports
Share

Manufacturers:

Merck & Co.Unknown ManufacturerSanofi PasteurBurroughs Wellcome

Rubella (Meruvax II) has 1,021 reports in VAERS spanning from 1990 to 2026. Of these reports, 3 mentioned death, 66 involved hospitalization, and 420 required emergency department visits. This vaccine is manufactured by: Merck & Co., Unknown Manufacturer, Sanofi Pasteur, Burroughs Wellcome. This vaccine accounts for 0.1% of all 1,983,260 reports in the VAERS database.

1,021
Total Reports
3
Deaths
66
Hospitalizations
420
ER Visits
68
Disabilities

About Rubella (Meruvax II)

Rubella (Meruvax II) has 1,021 reports in VAERS spanning from 1990 to 2026.

Of these reports, 3 mentioned death, 66 involved hospitalization, and 420 required emergency department visits.

This vaccine is manufactured by: Merck & Co., Unknown Manufacturer, Sanofi Pasteur, Burroughs Wellcome.

This vaccine accounts for 0.1% of all 1,983,260 reports in the VAERS database.

Reporting Rate

This vaccine averages 34 reports per year over 30 years of reporting (1990–2020).

Understanding These Numbers

•Reports don't prove causation. They represent temporal associations where someone experienced an event after vaccination.
•Background rates matter. Many conditions occur naturally and may coincidentally happen after vaccination.
•Reporting varies by vaccine. Newer vaccines or those in the news may have higher reporting rates due to increased awareness.

Most Reported Symptoms

1. Arthralgia(all)
324
2. Rash(all)
289
3. Pyrexia(all)
222
4. Lymphadenopathy(all)
139
5. Pain(all)
120
6. Drug ineffective(all)
87
7. Arthritis(all)
84
8. Headache(all)
83
9. Rash maculo-papular(all)
81
10. Pruritus(all)
81

Top Reporting States

1. New York147
2. California88
3. Florida73
4. New Jersey51
5. Illinois40
6. Michigan37
7. Pennsylvania35
8. Wisconsin31

Reports by Year

20168
20155
20145
201111
201021
200927
200814
200723
200618
200521

Explore Further

⚖️ Compare RUB with OthersRead Analysis Articles

Related Analysis

The Denominator ProblemUnderstanding Reporting BiasWhen Do Side Effects Start?Death Reports Deep DiveSerious Outcomes AnalysisMost Common Symptoms

Data Source

This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.